PURPLE BIOTECH LTD.

CIK 1614744 · 582 filings in 35 form types · 2014-08-18 to 2026-11-20 · PPBT

Former names: Kitov Pharma Ltd.; Kitov Pharmaceuticals Holdings Ltd.

FiledFormCategory8-K items / descriptionAccession
2026-11-20 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001614744-26-000011
2026-11-17 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001614744-26-000009
2026-11-12 SCHEDULE 13G Ownership 0001493152-26-051281
2026-11-10 EFFECT Registrations and prospectuses 9999999995-26-003492
2026-11-10 SCHEDULE 13G/A Ownership 0001213900-26-118162
2026-11-06 F-3/A Registrations and prospectuses 0001614744-26-000003
2026-10-05 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-106852
2026-09-09 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-098378
2026-09-02 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-096443
2026-08-14 SCHEDULE 13G/A Ownership 0001446580-26-000101
2026-08-10 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-087226
2026-08-07 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-086393
2026-07-29 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-082792
2026-06-23 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-070884
2026-06-11 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-067548
2026-05-20 F-3 Registrations and prospectuses 0001213900-26-059665
2026-05-15 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-057119
2026-05-13 SCHEDULE 13G/A Ownership 0001213900-26-055837
2026-04-27 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-047709
2026-04-23 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-046868
2026-04-17 3 Ownership 0001213900-26-044999
2026-04-07 3 Ownership 0001213900-26-040968
2026-04-06 3 Ownership 0001213900-26-040511
2026-03-31 3 Ownership 0001213900-26-036868
2026-03-30 3/A Ownership 0001213900-26-036407
2026-03-30 3 Ownership 0001213900-26-036361
2026-03-27 3 Ownership 0001213900-26-035282
2026-03-25 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-033843
2026-03-19 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-031366
2026-03-19 20-F Financial reports ANNUAL REPORT 0001213900-26-031365
2026-03-18 3 Ownership 0001213900-26-031048
2026-03-17 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-028642
2026-03-13 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-027273
2026-02-25 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-020391
2026-02-13 SCHEDULE 13G Ownership 0001446580-26-000041
2026-01-13 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-003591
2026-01-07 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-001970
2025-12-16 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-122236
2025-12-11 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-120341
2025-11-19 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-112706
2025-11-14 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-110379
2025-11-07 SCHEDULE 13G/A Ownership 0001213900-25-107727
2025-10-29 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-103254
2025-10-28 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-103079
2025-10-20 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-100353
2025-09-19 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-089661
2025-09-19 424B5 Registrations and prospectuses 0001213900-25-089578
2025-09-16 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-087788
2025-09-10 SCHEDULE 13G Ownership 0001213900-25-086630
2025-09-10 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-086377